To donate by check, phone, or other method, see our More Ways to Give page.

×
  • Home
  • jeff merkley
  • lead
  • troy jackson
  • michael brown
  • senate
  • center for biological diversity
  • arizona
  • election 2022
  • self-immolation
  • ukraine
  • russia
  • gaza
  • critical race theory
  • palestine
  • jan 6 insurrection
  • covid-19
  • george floyd
  • black lives matter
  • stacey abrams
  • trumpism
  • kyle rittenhouse
  • georgia
  • selma
  • john lewis
  • marjorie taylor greene
  • jared kushner
  • bernie sanders
  • sarah huckabee sanders
  • joe biden
  • kamala harris
  • jon ossoff
  • raphael warnock
  • election
  • midterm elections
  • big oil
  • fossil fuels
  • workers
  • inequality
  • minimum wage
  • poverty
  • environment
  • africa
  • food
  • hunger
  • animal rights
  • julian assange
  • amnesty international
  • united kingdom
  • wikileaks
  • biodiversity
  • new mexico
  • democracy
  • taxation
  • campaign finance
  • us supreme court
  • public health
  • oxfam
  • afghanistan
  • congressional progressive caucus
  • fight for the future
  • net neutrality
  • open internet
  • free press
  • anti-semitism
  • bend the arc
  • texas
  • cop26
  • 350.org
  • fcc
  • corporate power
  • jamie dimon
  • jpmorgan chase
  • stop the money pipeline
  • coronavirus
  • imf
  • jubilee usa
  • vaccines
  • florida
  • sustainability
  • center for responsive politics
  • amazon.com
  • drug policy alliance
  • marijuana
  • public citizen
  • environment america
  • renewable energy
  • aclu
  • war crimes
  • war on terror
  • immigration
  • refugees
  • arctic national wildlife refuge (anwr)
  • fossil fuel divestment
  • veterans
  • veterans for peace
  • oklahoma
  • racism
  • democratic party
  • people's action
  • republican party
  • us congress
  • budget
  • hyde amendment
  • reproductive rights
  • women
  • food & water watch
  • codepink
  • militarism
  • pentagon
  • us military
  • sunrise movement
  • filibuster
  • us house
  • war on drugs
  • common cause
  • indivisible
  • mitch mcconnell
  • stand up america
  • arctic
  • muslim ban
  • g7
  • patriotic millionaires
  • oregon
  • chris murphy
  • education
  • jamaal bowman
  • civil rights
  • ed markey
  • technology
  • infrastructure
  • moveon.org
  • egypt
  • journalism
  • barack obama
  • epa
  • pollution
  • war on science
  • voting rights
  • environmental working group
  • friends of the earth
  • icc
  • shell
  • methane
  • indigenous
  • line 3
  • healthcare
  • privatization
  • unemployment
  • labor
  • green new deal
  • data for progress
  • islamophobia
  • virginia
  • us department of justice
  • us senate
  • genocide
  • coal
  • iea
  • new york
  • facebook
  • police
  • big pharma
  • justice democrats
  • social security works
  • extreme weather
  • pesticides
  • bds
  • israel
  • plastics
  • fda
  • greenpeace
  • afge
  • alexandria ocasio-cortez
  • arms trade
  • benjamin netanyahu
  • cair
  • minnesota
  • super pacs
  • janet yellen
  • oil change international
  • wall street
  • factory farms
  • extremism
  • endangered species act
  • civil liberties
  • colombia
  • tony blinken
  • paris agreement
  • campaign legal center
  • fec
  • wto
  • criminal justice system
  • philadelphia
  • 9/11
  • center for food safety
  • monsanto
  • central america
  • mexico
  • children
  • mark pocan
  • rashida tlaib
  • chuck grassley
  • aipac
  • chuck schumer
  • jewish voice for peace
  • china
  • guantanamo
  • roe v. wade
  • jay inslee
  • at&t
  • corporate personhood
  • media
  • baltimore
  • naral
  • nina turner
  • center for reproductive rights
  • elon musk
  • jeff bezos
  • earthjustice
  • moveon
  • privacy
  • japan
  • rahm emanuel
  • apartheid
  • progressive international
  • coronavirus relief
  • agriculture
  • federal reserve
  • g20
  • people power
  • pennsylvania
  • wolves
  • demand progress
  • massachusetts
  • union of concerned scientists
  • human rights
  • nafta
  • asia
  • boris johnson
  • idaho
  • debt
  • sudan
  • world bank
  • keystone xl
  • syria
  • ilhan omar
  • kirsten gillibrand
  • usda
  • people for the american way
  • ron desantis
  • conservation
  • chevron
  • ecuador
  • steven donziger
  • deb haaland
  • us department of interior
    Common Dreams. To inform. To inspire. To ignite change for the common good.
    Common Dreams Globe
    LATEST NEWSOPINIONCLIMATEECONOMY POLITICS RIGHTS & JUSTICEWAR & PEACE
    LATEST NEWS
    OPINION
    Common DreamsTo inform. To inspire. To ignite change for the common good.

    patents

    A woman holds an Ozempic pen

    Sanders Praises FTC Challenge of 'Junk' Patents for Drugs Including Ozempic

    "We can no longer tolerate Novo Nordisk charging the American people $969 for Ozempic when that same exact drug can be purchased for just $155 in Canada and $59 in Germany while it costs less than $5 to manufacture."

    Jessica Corbett
    Apr 30, 2024

    U.S. Sen. Bernie Sanders on Tuesday lauded the Biden administration for expanding its "campaign against pharmaceutical manufacturers' improper or inaccurate listing of patents" for a wide range of drugs including Novo Nordisk's Ozempic.

    "Let me commend the Federal Trade Commission, under the leadership of Chair Lina Khan, for taking bold action today against the bogus patents Novo Nordisk has filed to prevent Americans struggling with diabetes from receiving a generic version of Ozempic at a much lower price," Sanders (I-Vt.) said in a statement.

    Keep ReadingShow Less
    bernie sanders
    big-pharma
    Activists protest at World Trade Organization headquarters

    WTO Pens 'Love Letter to Patents' as World Suffers From Big Pharma Greed

    The World Trade Organization posted a Valentine's Day-themed poem just hours after failing to challenge the pharmaceutical industry's monopoly control over Covid-19 tests and treatments.

    Jake Johnson
    Feb 14, 2024

    The World Trade Organization drew the ire of public health campaigners on Wednesday by failing to loosen the pharmaceutical industry's grip on Covid-19 tests and treatments—and subsequently posting to social media what one group described as a "love letter to patents."

    The WTO said Wednesday that "consensus could not be reached" on whether to waive patent rights on coronavirus therapeutics and tests, an announcement that Health Justice Initiative founder Fatima Hassan called "a real slap in the face."

    Keep ReadingShow Less
    vaccines
    world-trade-organization
    Engineer using laptop computer, futuristic technology

    US Trade Policy Shift on Big Tech Offers Hope Despite Huge Fights Ahead

    The implications of the U.S. withdrawal of support for extreme Big Tech trade provisions for developing countries

    and people across the world.

    Deborah James
    Dec 05, 2023

    On October 24, the U.S. government withdrew support for a set of proposals for digital trade rules in talks at the World Trade Organization (WTO) that the U.S. itself had proposed in 2019.

    With regard to negotiations on digital trade, or “e-commerce,” the Office of the U.S. Trade Representative stated: “many countries, including the United States, are examining their approaches to data and source code, and the impact of trade rules in these areas. In order to provide enough policy space for those debates to unfold, the United States has removed its support for proposals that might prejudice or hinder those domestic policy considerations.” However, variations on the proposed rules continue to be supported by other WTO members, as can be seen in the most recent leaked text, and it remains to be seen where the U.S. will sit in relation to those.

    Keep ReadingShow Less
    big tech
    big-tech
    FTC Chair Lina Khan

    Biden FTC Applauded for 'Going After Big Pharma' by Challenging 100+ Patents

    "We're thrilled to see the FTC crack down on over a hundred sham Orange Book listings, which keep lifesaving medicines like asthma inhalers and epinephrine prohibitively expensive for those who need them most."

    Jake Johnson
    Nov 08, 2023

    The Federal Trade Commission on Tuesday disputed more than 100 patents held by pharmaceutical companies that make asthma inhalers, EpiPens, and other items listed in the Food and Drug Administration's so-called "Orange Book," which identifies products the agency considers safe and effective.

    The FTC sent letters to 10 companies—including AbbVie, AstraZeneca, and Boehringer Ingelheim Pharmaceuticals—notifying them that the commission believes some of their patents are improperly listed in the FDA's Orange Book.

    Keep ReadingShow Less
    patents
    big-pharma

    SUBSCRIBE TO OUR FREE NEWSLETTER

    Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

    subscribe
    below
    * indicates required
    True
    True
    Follow Us
    Most Popular

    'Are We Really Living in a Democracy?' Asks Sanders After Musk Drops $10 Million on US Senate Race

    'Unchecked Corruption': First US Sale of Venezuelan Oil Goes to Company of Trump Megadonor

    Trump Declares 'There Can Be No Going Back' as Denmark Deploys More Troops to Greenland

    'The Fourth Amendment Literally Exists to Prevent This': Memo Claims ICE Can Forcibly Enter Homes Without Judicial Warrants

    Trump Pocketed At Least $1.4 Billion in First Year Back in Office in Unprecedented 'Exploitation of the Presidency'

    'Absolutely Vile': ICE Snatches Young Kids From Minnesota Schools, Sends Them to Texas

    ‘Sometimes You Need a Dictator,’ Trump Says Following Threats to Cancel Election

    Expert Who Ran Simulations on 'How Civil Wars Start' Warns Minnesota Is Exactly What It Looks Like

    Fury Grows Over Democrats Who Won't Back ICE Funding Freeze

    'Insane': Trump Threatens 8 Allies With New Tariffs for Opposing Greenland Takeover

    We cover the issues the corporate media never will.
    Please support our journalism.